ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
2.
ConfavreuxCHutchinsonMHoursMM, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med1998; 339(5): 285–291.
3.
FinkelsztejnABrooksJBPaschoalFMJr, et al. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG2011; 118(7): 790–797.
4.
VukusicSHutchinsonMHoursM, et al. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain2004; 127(Pt. 6): 1353–1360.
5.
HughesSESpelmanTGrayOM, et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler2014; 20(6): 739–746.
6.
MeinlIHavlaJHohlfeldR, et al. Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis. Mult Scler2018; 24(7): 991–994.
7.
NoviGGhezziAPizzornoM, et al. Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. Neurol Neuroimmunol Neuroinflamm2017; 4: e377.
8.
MartinelliVColomboBDallaCostaG, et al. Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. Mult Scler2016; 22(11): 1506–1508.
9.
AlroughaniRAlowayeshMSAhmedSF, et al. Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology2018; 90(10): e840–e846.
